United States Influenza Vaccines Market Revenue to see a Tremendous Rise Through 2028



The United States influenza vaccines market size to cross US$ 5.5 Billion by 2028.

Press Release

Amazon Music Disney Promo

This new market report presents an inclusive study of the entire United States influenza vaccines market. The report offers the most up–to–date industry data on the actual market situation and future outlook for the United States influenza vaccines market. The report also provides up–to–date market size data for the period 2015 – 2020 and an illustrative forecast to 2028 covering key market aspects like market value and volume for influenza vaccines.

Some of the Major Factors Contributing to the Growth of the Market:

  • The Surge in the COVID–19 Pandemic
  • Increased Disease Awareness
  • Introduction of the Quadrivalent Influenza Vaccines
  • Increasing Research and Development
  • Expanded Recommendations by Governmental and Advisory Bodies to be Vaccinated against Influenza Vaccines

Key Highlights:

  • The United States Rises to Become Largest Influenza Vaccines Market
  • The Demand for the Flu Vaccine is Expected to Increase in the Forecast Period Because of the COVID–19 Pandemic Surge
  • EpiVax to Design Antigens for Next–Generation Flu Vaccine
  • Versatope Therapeutics, Inc Awarded a Contract worth up to US$17.9 Million from the National Institute of Allergy and Infectious Diseases (NIAID)

For More [email protected] https://dpiresearch.com/u-s-influenza-flu-vaccines-market/

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact at [email protected]

Customization of the Report:

DPI Research provides customization of the report as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us:
Maria Rai
Head of Business Development
DPI Research
Direct Line: +91-766-764-8693
E-mail: [email protected]